Inpatient and Outpatient Orderable

BRCA1/2 Sequencing and Del/Dup Analysis

Synonyms

BRCA1/2 GENE SEQ.DEL/DU
BRCA1/2SEQ
LAB11059

Cerner Name

Clinical Info

This test is appropriate for patients to verify the genetic basis
of cancer in families indicative or suggestive of hereditary breast
and ovarian cancer syndrome. Results may help in determining
treatment and management, as well as identification of at-risk family members.

Specimen Sources

Blood, Arterial Blood, Capillary Blood, Central Line Blood, Venous

Specimen Types

Blood

Container

Lavender top tube or Buccal (Oral Cheek Swab)

Collection Instructions

Specimen Volume

2 - 5 mL whole blood

Transport Instructions

Room Temperature

Specimen Stability

7 Days Refrigerated
Blood samples older than 7 days can still be shipped, they will be tested if the yield and quality of DNA permit.

Methodology

Genotyping by Next Generation Sequencing

Days Performed

TAT: 14-15 Days

Performing Laboratory

GeneDx

CPT

81162

PDM

1659891

Only Orderable at Locations:

Orderable Everywhere

Results

Component Name	Base Name	Common Name	External Name
BRCA1/2 GENE SEQ.DEL/DU	BRCA12GENE	BRCA 1 2 GENE SEQ DEL DU	BRCA1/2 Gene Seq.Del/Du

Result Interpretation

See Report

Genes: BRCA1, BRCA2

Forms

LAB11059

Search: .supercomplete-item { width: 600px; white-space: nowrap; overflow: hidden; text-overflow: ellipsis; } $(document).ready(function() { $("#search_input").supercomplete(); });